Extract notice to the Minister
Epclusa
Common name / Subject : sofosbuvir/velpatasvir
Name of the manufacturer : Gilead
Form : Co.
Dosage : 400 mg - 100 mg
Name of the manufacturer : Gilead
Form : Co.
Dosage : 400 mg - 100 mg
Indication : Hépatite C chronique de génotypes 1 à 6
INESSS' Recommendation
-
Minister's decisions
Inscrire aux listes des médicaments – Médicament d’exception
Evaluation published on March 15, 2017